Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2012
12/27/2012WO2012177212A1 Activated carbon and iodine salts for treating depression
12/27/2012WO2012176934A1 Crystal of fused heterocyclic compound
12/27/2012WO2012176763A1 Novel indazole derivative
12/27/2012WO2012176659A1 Production method for casein-derived peptides by lactic acid fermentation
12/27/2012WO2012176658A1 Enzymatic production method for brain-function-improving peptides
12/27/2012WO2012176438A1 Sedative agent for vaporization and inhalation, and sedative perfume composition containing same
12/27/2012WO2012176066A1 Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia
12/27/2012WO2012176061A1 Trpv1 antagonists including dihydroxy substituent and uses thereof
12/27/2012WO2012175973A1 Combination treatment comprising a hdac6 inhibitor and an akt inhibitor
12/27/2012WO2012175894A1 Pharmaceutical composition for treating dependency in human beings
12/27/2012WO2012175747A1 Production method and dosage form
12/27/2012WO2012175714A1 Phenylbutyrate in rectal form for the treatment of a motor neuron disease or a metabolic disease
12/27/2012WO2012175531A1 Method of administration of 4-((1r,3s)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and the salts thereof in the treatment of schizophrenia
12/27/2012WO2012175434A1 Pharmaceutical formulations comprising vestipitant
12/27/2012WO2012175018A1 Traditional chinese medicine composition for promoting nerve regeneration and preparation method and use thereof
12/27/2012WO2012174730A1 Preparative method and use of zyj-d08a and its epimers as histone deacetylase inhibitors
12/27/2012WO2012174666A1 Methods for the prognostic and/or diagnostic of neurodegenerative disease, methods to identify candidate compounds and compounds for treating neurodegenerative disease
12/27/2012WO2012150829A3 Noble triazolopyridine derivative or pharmaceutically acceptable salts thereof, production method thereof, and pharmaceutical composition including same
12/27/2012WO2012148887A9 Acute cognitive and mood effects of plant polysaccharides in adult human subjects
12/27/2012WO2012142474A3 N-acetyl beta alanine methods of use
12/27/2012WO2012125413A3 Compositions for ameliorating systemic inflammation and methods for making and using them
12/27/2012WO2012095548A9 Dream inhibitors for treating neurodegenerative diseases
12/27/2012US20120331575 Transgenic non-human animals
12/27/2012US20120330224 Gas conditioning
12/27/2012US20120329990 B7-related nucleic acids and polypeptides useful for immunomodulation
12/27/2012US20120329877 Cycloalkyl-dione Derivatives And Methods Of Their Use
12/27/2012US20120329869 Benzyloxy anilide derivatives useful as potassium channel modulators
12/27/2012US20120329863 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
12/27/2012US20120329855 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf
12/27/2012US20120329851 D-serine transporter inhibitors as pharmaceutical compositions for the treatment of central nervous system disorders
12/27/2012US20120329843 Fatty acid amide hydrolase inhihibitors for treating pain
12/27/2012US20120329840 Novel modulators of sphingosine phosphate receptors
12/27/2012US20120329839 Novel modulators of sphingosine phosphate receptors
12/27/2012US20120329838 Novel modulators of sphingosine phosphate receptors
12/27/2012US20120329837 Cathepsin inhibitors for treating microglia-mediated neuron loss in the central nervous system
12/27/2012US20120329834 Compounds for the treatment of mitochondrial diseases
12/27/2012US20120329831 Pharmaceutical composition of donepezil
12/27/2012US20120329829 Dopamine Transporter Inhibitors for Use in Treatment of Movement Disorders and Other CNS Indications
12/27/2012US20120329828 Cocaine Analogs and Methods of Preparation and Uses Thereof
12/27/2012US20120329820 Pyridinoylpiperidines As 5-HT1F Agonists
12/27/2012US20120329816 Methods for Altering MRNA Splicing and Treating Familial Dysautonomia and Other Mechanistically Related Disorders
12/27/2012US20120329812 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
12/27/2012US20120329811 Heteroaromatic Derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
12/27/2012US20120329809 Purine compounds used as cb2 agonists
12/27/2012US20120329808 Dihydrothieno pyrimidines as akt protein kinase inhibitors
12/27/2012US20120329807 Multimeric VLA-4 Antagonists Comprising Polymers Moieties
12/27/2012US20120329806 Novel fluoroergoline analogs
12/27/2012US20120329803 Dihydropteridinones, method for production and use thereof
12/27/2012US20120329802 Metalloenzyme inhibitor compounds
12/27/2012US20120329792 IMIDAZO[1,2-a]PYRAZINE DERIVATIVES AND THEIR USE FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC AND METABOLIC DISORDERS AND DISEASES
12/27/2012US20120329789 Compositions and methods for treating alzheimers disease
12/27/2012US20120329783 Compositions and methods for selective inhibition of nicotine acetylcholine receptors
12/27/2012US20120329781 Combinations comprising alpha-2-delta ligands
12/27/2012US20120329777 Amino-Heterocyclic Compounds
12/27/2012US20120329774 Thieno-pyridine derivatives as mek inhibitors
12/27/2012US20120329773 Bicyclic ring system substituted amide functionalised phenols as medicaments
12/27/2012US20120329772 Amino-tetrazoles analogues and methods of use
12/27/2012US20120329764 Methods and compositions for the treatment of migraine headaches
12/27/2012US20120329749 Methods Of Preventing Or Treating Disease States Related To Certain Metabolic Abnormalities
12/27/2012US20120329734 Mixture and infusion or drink solution
12/27/2012US20120329727 Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense transcript to ucp2
12/27/2012US20120329724 Peptide analogues
12/27/2012US20120329723 Biological Agents Active in Central Nervous System
12/27/2012US20120329722 Method for enzymatically preparing peptides for use in improvement of brain function
12/27/2012US20120329721 Means for preventing and treating cellular death and their biological applications
12/27/2012US20120329717 Novel omega conotoxin peptides
12/27/2012US20120329715 Glp-1, exendin-4, peptide analogs and uses thereof
12/27/2012US20120329714 Prolactin Induced Increase in Neural Stem Cell Numbers
12/27/2012US20120329708 Glucagon/glp-1 receptor co-agonists
12/27/2012US20120329707 Glucagon/glp-1 receptor co-agonists
12/27/2012US20120329705 Compounds for proteasome enzyme inhibition
12/27/2012US20120328720 Iridoid Based Formulations
12/27/2012US20120328718 Pharmaceutical compositions
12/27/2012US20120328717 Pharmaceutical kit for treating neuronal damages
12/27/2012US20120328712 Carbon monoxide releasing rhenium compounds for medical use
12/27/2012US20120328707 Multi-particulate pharmaceutical formulation for colon absorption
12/27/2012US20120328702 Nanoparticle compositions
12/27/2012US20120328701 Nanoparticle compositions, formulations thereof, and uses therefor
12/27/2012US20120328696 Anti-parkinsonian compound acetylsalicylic acid maltol ester
12/27/2012US20120328695 Compositions and methods for treatment of chronic fatigue
12/27/2012US20120328679 Solid pharmaceutical dispersions with enhanced bioavailability
12/27/2012US20120328661 Coumarin compounds as receptor modulators with therapeutic utility
12/27/2012US20120328643 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
12/27/2012US20120328635 Chaperonin 10 variants
12/27/2012US20120328634 Immunoconjugates with an Intracellularly-Cleavable Linkage
12/27/2012US20120328633 T cell activation inhibitor, pharmaceutical composition containing same, and screening method for t cell activation inhibiting substance
12/27/2012US20120328632 Inhibition of leukocyte adhesion
12/27/2012US20120328629 Therapeutic Applications Targeting SARM1
12/27/2012US20120328628 Antibodies to conformationally trapped proteins
12/27/2012US20120328617 Method for inhibiting angiogenesis
12/27/2012US20120328609 Modulation of Axon Degeneration
12/27/2012US20120328605 Compositions and uses
12/27/2012US20120328602 Compositions and methods for treating conditions associated with ceramide biosynthesis
12/27/2012US20120328601 Modulation of Synaptic Maintenance
12/27/2012US20120328582 Primate Embryonic Stem Cells
12/27/2012US20120328574 P38 inhibitors
12/27/2012US20120328566 Estrogen receptor ligand treatment for neurodegenerative diseases
12/27/2012US20120328533 Hypnotic compositions and methods of use thereof
12/27/2012US20120328526 Modulation of Nad+ Activity in Neuropathophysiological Conditions and Uses Thereof
12/27/2012US20120328525 Nanoparticle compositions and components thereof
1 ... 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 ... 1833